We share our deep understanding of biology with partner biopharmaceutical companies across diverse therapeutic areas to discover breakthrough therapies and develop them across the pharma pipeline. We also partner with many private and public organizations who have built strategically important biological and clinical patient datasets.
Aitia Expands Collaboration with Servier
to Discover and Develop New Drugs for Brain
Cancer Using AI-Driven Digital Twins
